Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target
Who will win, Trump or Harris? The Dow predicts a 92% chance of winning the election.
The performance of the Dow before the election day 11 weeks, is related to whether the ruling party candidate has won the presidential election since 1968.
Biden-Harris Administration Proposes Medicare $2 Drug List Model To Lower Prescription Costs; CMS Seeks Feedback On Sample Drug List And Outreach With Voluntary Participation For Part D Sponsors Starting As Early As Jan 2027; Model To Include Drugs...
Is Humana a Deep Value Stock to Buy?
Humana Raised to Outperform From Market Perform by Bernstein
Evolent Health Shows Long-Term Growth Prospects Despite Humana, Cigna Combination Uncertainty, RBC Says
Humana Gets a Rare Stock Upgrade at Wall Street Amid Recent Woes
Humana Ends Selloff as Bernstein Upgrades on Attractive Entry Point
Humana Is Maintained at Outperform by RBC Capital
Humana Analyst Ratings
RBC Capital Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $265
RBC Cuts Price Target on Humana to $265 From $400, Keeps Outperform Rating
RBC Capital Reaffirms Their Buy Rating on Humana (HUM)
Cognizant's Revenue Outlook: A Hold Rating Amidst Humana's Anticipated Spending Changes
Bernstein Upgrades Humana(HUM.US) to Buy Rating, Cuts Target Price to $308
Bernstein lowers Humana's target price to $308.
October 8th, Guolonghui | Bernstein: Upgraded Humana's rating from "in line with the market" to "outperforming the market", and reduced the target price from $405 to $308.
Bernstein Upgrades Humana to Outperform From Market Perform, Adjusts Price Target to $308 From $405
Humana Inc. (HUM): Among Seth Klarman's Top Stock Picks
10 Health Care Stocks Whale Activity In Today's Session
Top Stock Movers Now: Humana, Amazon, Apple, and More